Skip to main content

Table 4 Adjuvant therapy, recurrence and outcome of long-term survival cases of adult undifferentiated embronal sarcoma

From: A long-term survival case of adult undifferentiated embryonal sarcoma of liver

Reference

Year

Age

Resection margin

Adjuvant treatment

Recurrence

Treatment for recurrence

Follow-up months)

Outcome

Grazi [9]

1996

25

Positive

None

Liver

Re-resection, two times

67.6

DOD

Alomogy [17]

2005

21

Negative

I + ADM, Re-resectionI + ADM

None

 

77

NED

Lenze [16]

2008

34

Negative

None

Liver

CBDCA + VP-16  + ADM + I

72

NED

Present

2011

27

Negative

DDP + VCR + ADM + ACTRT + PBSCT (VP-16, MCNU, CBDNU, CBDCA, CTX)

None

 

60

NED

  1. ACT, actinomycin D; ADM, doxorubicin; CBDCA, carboplatin; CTX, cyclophosphamide; DDP, cisplatin; DOD, dead of disease; I, ifosfamide; MCNU, ranimustine, NED, no evidence of disease; PBSCT, pheripheral blood stem cell transplantation; RT, radiotherapy; VCR, vincritine; VP-16, Etoposide.